These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15585635)

  • 21. Analysis of multidrug effects by parameter method.
    Zheng QS; Sun RY
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):232-7. PubMed ID: 10375732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical mixture toxicity testing with Vibrio fischeri: combined effects of binary mixtures for ten soft electrophiles.
    Dawson DA; Pöch G; Schultz TW
    Ecotoxicol Environ Saf; 2006 Oct; 65(2):171-80. PubMed ID: 16139365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical analysis of combined dose effects for experiments with two agents.
    Wagenpfeil S; Treiber U; Lehmer A
    Artif Intell Med; 2006 May; 37(1):65-71. PubMed ID: 16497492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedure to normalize data for benchmarking.
    Chatburn RL; Ford RM
    Respir Care; 2006 Feb; 51(2):145-57. PubMed ID: 16441959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
    Thall PF; Logothetis C; Pagliaro LC; Wen S; Brown MA; Williams D; Millikan RE
    J Natl Cancer Inst; 2007 Nov; 99(21):1613-22. PubMed ID: 17971530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
    Abramjuk C; Lein M; Rothaug W; Krell HW; Loening SA; Jung K
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):275-82. PubMed ID: 16758188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of drug interactions in combined drug therapy by reflection method.
    Zheng QS; Sun RY
    Acta Pharmacol Sin; 2000 Feb; 21(2):183-7. PubMed ID: 11263269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
    Xin Y; Lyness G; Chen D; Song S; Wientjes MG; Au JL
    J Urol; 2005 Jul; 174(1):322-7. PubMed ID: 15947683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of theoretical considerations to the analysis of ELISA data.
    Peterman JH; Butler JE
    Biotechniques; 1989 Jun; 7(6):608-15. PubMed ID: 2631779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical versus clinical drug combination studies.
    Chou TC
    Leuk Lymphoma; 2008 Nov; 49(11):2059-80. PubMed ID: 19021049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The application of robust calibration to radioimmunoassay.
    Tiede JJ; Pagano M
    Biometrics; 1979 Sep; 35(3):567-74. PubMed ID: 497342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fitting curves to data using nonlinear regression: a practical and nonmathematical review.
    Motulsky HJ; Ransnas LA
    FASEB J; 1987 Nov; 1(5):365-74. PubMed ID: 3315805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of methods for evaluating drug-drug interaction.
    Zhao L; Au JL; Wientjes MG
    Front Biosci (Elite Ed); 2010 Jan; 2(1):241-9. PubMed ID: 20036874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of methods for estimating carbonaceous BOD parameters.
    Uludag-Demirer S; Demirer GN; Bowers AR
    Environ Technol; 2001 Aug; 22(8):915-26. PubMed ID: 11561949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
    Grenczer M; Zsuga J; Majoros L; Pinter A; Kemeny-Beke A; Juhasz B; Tosaki A; Gesztelyi R
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1074-83. PubMed ID: 21076495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A program for analyzing enzyme rate data obtained from a microplate reader.
    Brooks SP
    Biotechniques; 1994 Dec; 17(6):1154-61. PubMed ID: 7873186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.